{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:01:15Z","timestamp":1795122075781,"version":"4.10.3"},"reference-count":90,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Inflammation contributes to morbidity following subarachnoid hemorrhage (SAH). The authors of this study evaluate how applying noninvasive transauricular vagus nerve stimulation (taVNS) can target this deleterious inflammatory response following SAH and reduce the rate of radiographic vasospasm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>In this prospective, triple-blinded, randomized controlled trial, 27 patients were randomized to taVNS or sham stimulation. Serial blood and CSF samples were collected every 3 days to quantify inflammatory markers. Radiographic cerebral vasospasm severity and functional outcomes (modified Rankin Scale scores) were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>No adverse events occurred. Radiographic vasospasm was significantly reduced (p = 0.018), with serial vessel caliber measurements demonstrating a more rapid return to normal than in the sham-treated group (p &lt; 0.001). In the taVNS group, tumor necrosis factor\u2013\u03b1 was significantly reduced in both plasma (days 7 and 10) and CSF (day 13); interleukin-6 was also significantly reduced in plasma (day 4) and CSF (day 13) (p &lt; 0.05). Patients receiving taVNS had higher rates of favorable outcomes at discharge (38.4% vs 21.4%) and first follow-up (76.9% vs 57.1%). Patients treated with taVNS had significant improvement in modified Rankin Scale scores from admission to first follow-up (p = 0.014), unlike patients in the sham-treated group (p = 0.18). The taVNS group had a significantly lower rate of discharge to a skilled nursing facility or hospice (p = 0.04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>taVNS is a noninvasive method of neuro- and systemic immunomodulation. This trial supports the finding that taVNS following SAH can mitigate the inflammatory response, reduce radiographic vasospasm, and potentially improve functional and neurological outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2024.10.jns241643","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T20:28:02Z","timestamp":1737750482000},"page":"1720-1731","source":"Crossref","is-referenced-by-count":18,"title":["Auricular vagus nerve stimulation for mitigation of inflammation and vasospasm in subarachnoid hemorrhage: a single-institution randomized controlled trial"],"prefix":"10.3171","volume":"142","author":[{"given":"Anna L.","family":"Huguenard","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Division of Neurotechnology, Washington University in St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gansheng","family":"Tan","sequence":"additional","affiliation":[{"name":"Biomedical Engineering, and"},{"name":"Division of Neurotechnology, Washington University in St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Rivet","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Public Health Sciences, Washington University in St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle W.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Adamek","sequence":"additional","affiliation":[{"name":"Biomedical Engineering, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Coxon","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrance T.","family":"Kummer","sequence":"additional","affiliation":[{"name":"Neurology, Washington University in St. Louis, Missouri;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.","family":"Osbun","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Division of Neurotechnology, Washington University in St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth K.","family":"Vellimana","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Limbrick","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Zipfel","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brunner","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Biomedical Engineering, and"},{"name":"Division of Neurotechnology, Washington University in St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Leuthardt","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Biomedical Engineering, and"},{"name":"Division of Neurotechnology, Washington University in St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"8","key":"b1","series-title":"Stroke","first-page":"e519","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi T","year":"2010","unstructured":"Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519\u2013e536."},{"issue":"1","key":"b2","series-title":"Nat Commun","first-page":"1850","article-title":"Diagnosis and management of subarachnoid haemorrhage","volume":"15","author":"Thilak S","year":"2024","unstructured":"Thilak S, Brown P, Whitehouse T,  Diagnosis and management of subarachnoid haemorrhage. Nat Commun. 2024;15(1):1850."},{"issue":"3","key":"b3","series-title":"J Neurosurg Sci","first-page":"245","article-title":"The relationship between IL-6, ET-1 and cerebral vasospasm, in experimental rabbit subarachnoid hemorrhage","volume":"63","author":"Croci D","year":"2019","unstructured":"Croci D, Nevzati E, Danura H,  The relationship between IL-6, ET-1 and cerebral vasospasm, in experimental rabbit subarachnoid hemorrhage. J Neurosurg Sci. 2019;63(3):245\u2013250."},{"issue":"2","key":"b4","series-title":"J Neurol Surg A Cent Eur Neurosurg","first-page":"145","article-title":"Early dynamics of interleukin-6 in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage","volume":"79","author":"\u010euri\u0161 K","year":"2018","unstructured":"\u010euri\u0161 K, Neuman E, Vyb\u00edhal V,  Early dynamics of interleukin-6 in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage. J Neurol Surg A Cent Eur Neurosurg. 2018;79(2):145\u2013151."},{"key":"b5","series-title":"World Neurosurg","first-page":"e612","article-title":"Interleukin-6 levels in cerebrospinal fluid and plasma in patients with severe spontaneous subarachnoid hemorrhage","volume":"122","author":"Vlachogiannis P","year":"2019","unstructured":"Vlachogiannis P, Hillered L, Khalil F, Enblad P, Ronne-Engstr\u00f6m E. Interleukin-6 levels in cerebrospinal fluid and plasma in patients with severe spontaneous subarachnoid hemorrhage. World Neurosurg. 2019;122:e612\u2013e618."},{"key":"b6","series-title":"World Neurosurg","first-page":"e362","article-title":"Levels of interleukin-1\u03b2, interleukin-18, and tumor necrosis factor-\u03b1 in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients may be predictors of early brain injury and clinical prognosis","volume":"111","author":"Lv SY","year":"2018","unstructured":"Lv SY, Wu Q, Liu JP,  Levels of interleukin-1\u03b2, interleukin-18, and tumor necrosis factor-\u03b1 in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients may be predictors of early brain injury and clinical prognosis. World Neurosurg. 2018;111:e362\u2013e373."},{"issue":"4","key":"b7","series-title":"Int J Mol Sci","first-page":"497","article-title":"Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review","volume":"17","author":"Lucke-Wold BP","year":"2016","unstructured":"Lucke-Wold BP, Logsdon AF, Manoranjan B,  Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci. 2016;17(4):497."},{"key":"b8","series-title":"Front Neurol","first-page":"292","article-title":"Neuroinflammation as a target for intervention in subarachnoid hemorrhage","volume":"9","author":"de Oliveira Manoel AL","year":"2018","unstructured":"de Oliveira Manoel AL, Macdonald RL. Neuroinflammation as a target for intervention in subarachnoid hemorrhage. Front Neurol. 2018;9:292."},{"issue":"6921","key":"b9","series-title":"Nature","first-page":"384","article-title":"Nicotinic acetylcholine receptor \u03b17 subunit is an essential regulator of inflammation","volume":"421","author":"Wang H","year":"2003","unstructured":"Wang H, Yu M, Ochani M,  Nicotinic acetylcholine receptor \u03b17 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384\u2013388."},{"issue":"29","key":"b10","series-title":"Proc Natl Acad Sci U S A","first-page":"8284","article-title":"Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis","volume":"113","author":"Koopman FA","year":"2016","unstructured":"Koopman FA, Chavan SS, Miljko S,  Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113(29):8284\u20138289."},{"issue":"1","key":"b11","series-title":"J Intern Med","first-page":"64","article-title":"Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis","volume":"282","author":"Koopman FA","year":"2017","unstructured":"Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med. 2017;282(1):64\u201375."},{"issue":"12","key":"b12","series-title":"Crit Care Med","first-page":"2762","article-title":"Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis","volume":"35","author":"Huston JM","year":"2007","unstructured":"Huston JM, Gallowitsch-Puerta M, Ochani M,  Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med. 2007;35(12):2762\u20132768."},{"issue":"10","key":"b13","series-title":"Neurogastroenterol Motil","first-page":"e13911","article-title":"A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease","volume":"32","author":"Sinniger V","year":"2020","unstructured":"Sinniger V, Pellissier S, Fauvelle F,  A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease. Neurogastroenterol Motil. 2020;32(10):e13911."},{"issue":"4","key":"b14","series-title":"J Anat","first-page":"588","article-title":"The anatomical basis for transcutaneous auricular vagus nerve stimulation","volume":"236","author":"Butt MF","year":"2020","unstructured":"Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat. 2020;236(4):588\u2013611."},{"key":"b15","series-title":"medRxiv","article-title":"Non-invasive auricular vagus nerve stimulation for subarachnoid hemorrhage (NAVSaH): protocol for a prospective, triple-blinded, randomized controlled trial","author":"Huguenard AL","unstructured":"Huguenard AL, Tan G, Johnson GW,  Non-invasive auricular vagus nerve stimulation for subarachnoid hemorrhage (NAVSaH): protocol for a prospective, triple-blinded, randomized controlled trial. medRxiv. Preprint posted online March 19, 2024. doi:10.1101\/2024.03.18.24304239."},{"key":"b16","series-title":"BMJ","first-page":"c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz KF","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332."},{"key":"b17","series-title":"Front Neurosci","first-page":"284","article-title":"Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice","volume":"14","author":"Yap JYY","year":"2020","unstructured":"Yap JYY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T. Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice. Front Neurosci. 2020;14:284."},{"key":"b18","series-title":"Front Psychol","first-page":"1159","article-title":"Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during sequential action","volume":"9","author":"Jongkees BJ","year":"2018","unstructured":"Jongkees BJ, Immink MA, Finisguerra A, Colzato LS. Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during sequential action. Front Psychol. 2018;9:1159."},{"issue":"1","key":"b19","series-title":"J Neurosurg","first-page":"152","article-title":"Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"133","author":"Athiraman U","year":"2019","unstructured":"Athiraman U, Aum D, Vellimana AK,  Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019;133(1):152\u2013158."},{"issue":"7","key":"b20","series-title":"J Investig Med","first-page":"1054","article-title":"Early elevation of serum tumor necrosis factor-\u03b1 is associated with poor outcome in subarachnoid hemorrhage","volume":"60","author":"Chou SHY","year":"2012","unstructured":"Chou SHY, Feske SK, Atherton J,  Early elevation of serum tumor necrosis factor-\u03b1 is associated with poor outcome in subarachnoid hemorrhage. J Investig Med. 2012;60(7):1054\u20131058."},{"issue":"3","key":"b21","series-title":"Neurocrit Care","first-page":"679","article-title":"TNF-R1 correlates with cerebral perfusion and acute ischemia following subarachnoid hemorrhage","volume":"33","author":"Fragata I","year":"2020","unstructured":"Fragata I, Bustamante A, Penalba A,  TNF-R1 correlates with cerebral perfusion and acute ischemia following subarachnoid hemorrhage. Neurocrit Care. 2020;33(3):679\u2013687."},{"issue":"1","key":"b22","series-title":"Stroke","first-page":"212","article-title":"Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage","volume":"32","author":"Aihara Y","year":"2001","unstructured":"Aihara Y, Kasuya H, Onda H, Hori T, Takeda J. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke. 2001;32(1):212\u2013217."},{"issue":"4","key":"b23","series-title":"J Neurol Neurosurg Psychiatry","first-page":"534","article-title":"Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries","volume":"70","author":"Fassbender K","year":"2001","unstructured":"Fassbender K, Hodapp B, Rossol S,  Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70(4):534\u2013537."},{"issue":"1","key":"b24","series-title":"Sci Rep","first-page":"12","article-title":"Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage","volume":"11","author":"Ridwan S","year":"2021","unstructured":"Ridwan S, Grote A, Simon M. Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage. Sci Rep. 2021;11(1):12."},{"issue":"Pt 1","key":"b25","series-title":"Acta Neurochir Suppl","first-page":"203","article-title":"The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage","volume":"110","author":"Ni W","year":"2011","unstructured":"Ni W, Gu YX, Song DL, Leng B, Li PL, Mao Y. The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;110(Pt 1):203\u2013208."},{"issue":"9","key":"b26","series-title":"Curr Neuropharmacol","first-page":"1385","article-title":"Inflammatory events following subarachnoid hemorrhage (SAH)","volume":"16","author":"Schneider UC","year":"2018","unstructured":"Schneider UC, Xu R, Vajkoczy P. Inflammatory events following subarachnoid hemorrhage (SAH). Curr Neuropharmacol. 2018;16(9):1385\u20131395."},{"issue":"2","key":"b27","series-title":"Neurosurgery","first-page":"289","article-title":"The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study","volume":"40","author":"Manno EM","year":"1997","unstructured":"Manno EM, Gress DR, Ogilvy CS, Stone CM, Zervas NT. The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study. Neurosurgery. 1997;40(2):289\u2013293."},{"issue":"3","key":"b28","series-title":"J Neurosurg","first-page":"681","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage","volume":"112","author":"Gomis P","year":"2010","unstructured":"Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2010;112(3):681\u2013688."},{"key":"b29","series-title":"World Neurosurg","first-page":"e655","article-title":"A propensity score analysis of the impact of dexamethasone use on delayed cerebral ischemia and poor functional outcomes after subarachnoid hemorrhage","volume":"109","author":"Mohney N","year":"2018","unstructured":"Mohney N, Williamson CA, Rothman E,  A propensity score analysis of the impact of dexamethasone use on delayed cerebral ischemia and poor functional outcomes after subarachnoid hemorrhage. World Neurosurg. 2018;109:e655\u2013e661."},{"issue":"1-2","key":"b30","series-title":"Cerebrovasc Dis","first-page":"59","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura M","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis. 2017;44(1-2):59\u201367."},{"issue":"1","key":"b31","series-title":"J Neurosurg","first-page":"121","article-title":"Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial","volume":"118","author":"Senbokuya N","year":"2013","unstructured":"Senbokuya N, Kinouchi H, Kanemaru K,  Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118(1):121\u2013130."},{"issue":"2","key":"b32","series-title":"J Neurosurg","first-page":"515","article-title":"Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study","volume":"128","author":"Galea J","year":"2018","unstructured":"Galea J, Ogungbenro K, Hulme S,  Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg. 2018;128(2):515\u2013523."},{"issue":"12","key":"b33","series-title":"Am J Emerg Med","first-page":"1940","article-title":"Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"35","author":"Liu H","year":"2017","unstructured":"Liu H, Xu X. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Am J Emerg Med. 2017;35(12):1940\u20131945."},{"issue":"4","key":"b34","series-title":"Cochrane Database Syst Rev","first-page":"CD006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Dorhout Mees SM","year":"2007","unstructured":"Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJE. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(4):CD006184."},{"issue":"1","key":"b35","series-title":"J Neurosurg","first-page":"180","article-title":"Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials","volume":"119","author":"Shen J","year":"2013","unstructured":"Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. J Neurosurg. 2013;119(1):180\u2013189."},{"issue":"12","key":"b36","series-title":"J Clin Med","first-page":"4165","article-title":"Anti-inflammatory drug therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective randomized and placebo-controlled trials","volume":"12","author":"Wach J","year":"2023","unstructured":"Wach J, Vychopen M, G\u00fcresir A, G\u00fcresir E. Anti-inflammatory drug therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective randomized and placebo-controlled trials. J Clin Med. 2023;12(12):4165."},{"issue":"2","key":"b37","series-title":"Nat Neurosci","first-page":"156","article-title":"Neural regulation of immunity: molecular mechanisms and clinical translation","volume":"20","author":"Pavlov VA","year":"2017","unstructured":"Pavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci. 2017;20(2):156\u2013166."},{"issue":"2","key":"b38","series-title":"J Mol Neurosci","first-page":"217","article-title":"Non-invasive vagus nerve stimulation protects against cerebral ischemia\/reperfusion injury and promotes microglial M2 polarization via interleukin-17A inhibition","volume":"67","author":"Zhao XP","year":"2019","unstructured":"Zhao XP, Zhao Y, Qin XY, Wan LY, Fan XX. Non-invasive vagus nerve stimulation protects against cerebral ischemia\/reperfusion injury and promotes microglial M2 polarization via interleukin-17A inhibition. J Mol Neurosci. 2019;67(2):217\u2013226."},{"issue":"5","key":"b39","series-title":"Stroke","first-page":"1216","article-title":"Noninvasive vagus nerve stimulation prevents ruptures and improves outcomes in a model of intracranial aneurysm in mice","volume":"50","author":"Suzuki T","year":"2019","unstructured":"Suzuki T, Takizawa T, Kamio Y,  Noninvasive vagus nerve stimulation prevents ruptures and improves outcomes in a model of intracranial aneurysm in mice. Stroke. 2019;50(5):1216\u20131223."},{"key":"b40","series-title":"BioMed Res Int","first-page":"628597","article-title":"To look beyond vasospasm in aneurysmal subarachnoid haemorrhage","volume":"2014","author":"Cossu G","year":"2014","unstructured":"Cossu G, Messerer M, Oddo M, Daniel RT. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage. BioMed Res Int. 2014;2014:628597."},{"issue":"1","key":"b41","series-title":"J Neurochem","first-page":"34","article-title":"Central sympathetic nerve activation in subarachnoid hemorrhage","volume":"160","author":"Hasegawa Y","year":"2022","unstructured":"Hasegawa Y, Uchikawa H, Kajiwara S, Morioka M. Central sympathetic nerve activation in subarachnoid hemorrhage. J Neurochem. 2022;160(1):34\u201350."},{"key":"b42","series-title":"eLife","first-page":"RP100088","article-title":"The effect of transcutaneous auricular vagus nerve stimulation on cardiovascular function in subarachnoid hemorrhage patients: a randomized trial","volume":"13","author":"Tan G","year":"2025","unstructured":"Tan G, Huguenard AL, Donovan KM,  The effect of transcutaneous auricular vagus nerve stimulation on cardiovascular function in subarachnoid hemorrhage patients: a randomized trial. eLife. 2025;13:RP100088."},{"issue":"10","key":"b43","series-title":"Reg Anesth Pain Med","first-page":"513","article-title":"Cervical sympathectomy to treat cerebral vasospasm: a scoping review","volume":"48","author":"Bombardieri AM","year":"2023","unstructured":"Bombardieri AM, Heifets BD, Treggiari M, Albers GW, Steinberg GK, Heit JJ. Cervical sympathectomy to treat cerebral vasospasm: a scoping review. Reg Anesth Pain Med. 2023;48(10):513\u2013519."},{"issue":"2","key":"b44","series-title":"Neurotherapeutics","first-page":"497","article-title":"Spreading depolarizations and subarachnoid hemorrhage","volume":"17","author":"Sugimoto K","year":"2020","unstructured":"Sugimoto K, Chung DY. Spreading depolarizations and subarachnoid hemorrhage. Neurotherapeutics. 2020;17(2):497\u2013510."},{"issue":"4","key":"b45","series-title":"Pain","first-page":"797","article-title":"Vagus nerve stimulation inhibits cortical spreading depression","volume":"157","author":"Chen SP","year":"2016","unstructured":"Chen SP, Ay I, Lopes de Morais A,  Vagus nerve stimulation inhibits cortical spreading depression. Pain. 2016;157(4):797\u2013805."},{"issue":"8","key":"b1","series-title":"Stroke","first-page":"e519","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi T","year":"2010","unstructured":"Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519\u2013e536."},{"issue":"1","key":"b2","series-title":"Nat Commun","first-page":"1850","article-title":"Diagnosis and management of subarachnoid haemorrhage","volume":"15","author":"Thilak S","year":"2024","unstructured":"Thilak S, Brown P, Whitehouse T,  Diagnosis and management of subarachnoid haemorrhage. Nat Commun. 2024;15(1):1850."},{"issue":"3","key":"b3","series-title":"J Neurosurg Sci","first-page":"245","article-title":"The relationship between IL-6, ET-1 and cerebral vasospasm, in experimental rabbit subarachnoid hemorrhage","volume":"63","author":"Croci D","year":"2019","unstructured":"Croci D, Nevzati E, Danura H,  The relationship between IL-6, ET-1 and cerebral vasospasm, in experimental rabbit subarachnoid hemorrhage. J Neurosurg Sci. 2019;63(3):245\u2013250."},{"issue":"2","key":"b4","series-title":"J Neurol Surg A Cent Eur Neurosurg","first-page":"145","article-title":"Early dynamics of interleukin-6 in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage","volume":"79","author":"\u010euri\u0161 K","year":"2018","unstructured":"\u010euri\u0161 K, Neuman E, Vyb\u00edhal V,  Early dynamics of interleukin-6 in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage. J Neurol Surg A Cent Eur Neurosurg. 2018;79(2):145\u2013151."},{"key":"b5","series-title":"World Neurosurg","first-page":"e612","article-title":"Interleukin-6 levels in cerebrospinal fluid and plasma in patients with severe spontaneous subarachnoid hemorrhage","volume":"122","author":"Vlachogiannis P","year":"2019","unstructured":"Vlachogiannis P, Hillered L, Khalil F, Enblad P, Ronne-Engstr\u00f6m E. Interleukin-6 levels in cerebrospinal fluid and plasma in patients with severe spontaneous subarachnoid hemorrhage. World Neurosurg. 2019;122:e612\u2013e618."},{"key":"b6","series-title":"World Neurosurg","first-page":"e362","article-title":"Levels of interleukin-1\u03b2, interleukin-18, and tumor necrosis factor-\u03b1 in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients may be predictors of early brain injury and clinical prognosis","volume":"111","author":"Lv SY","year":"2018","unstructured":"Lv SY, Wu Q, Liu JP,  Levels of interleukin-1\u03b2, interleukin-18, and tumor necrosis factor-\u03b1 in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients may be predictors of early brain injury and clinical prognosis. World Neurosurg. 2018;111:e362\u2013e373."},{"issue":"4","key":"b7","series-title":"Int J Mol Sci","first-page":"497","article-title":"Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review","volume":"17","author":"Lucke-Wold BP","year":"2016","unstructured":"Lucke-Wold BP, Logsdon AF, Manoranjan B,  Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci. 2016;17(4):497."},{"key":"b8","series-title":"Front Neurol","first-page":"292","article-title":"Neuroinflammation as a target for intervention in subarachnoid hemorrhage","volume":"9","author":"de Oliveira Manoel AL","year":"2018","unstructured":"de Oliveira Manoel AL, Macdonald RL. Neuroinflammation as a target for intervention in subarachnoid hemorrhage. Front Neurol. 2018;9:292."},{"issue":"6921","key":"b9","series-title":"Nature","first-page":"384","article-title":"Nicotinic acetylcholine receptor \u03b17 subunit is an essential regulator of inflammation","volume":"421","author":"Wang H","year":"2003","unstructured":"Wang H, Yu M, Ochani M,  Nicotinic acetylcholine receptor \u03b17 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384\u2013388."},{"issue":"29","key":"b10","series-title":"Proc Natl Acad Sci U S A","first-page":"8284","article-title":"Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis","volume":"113","author":"Koopman FA","year":"2016","unstructured":"Koopman FA, Chavan SS, Miljko S,  Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113(29):8284\u20138289."},{"issue":"1","key":"b11","series-title":"J Intern Med","first-page":"64","article-title":"Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis","volume":"282","author":"Koopman FA","year":"2017","unstructured":"Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med. 2017;282(1):64\u201375."},{"issue":"12","key":"b12","series-title":"Crit Care Med","first-page":"2762","article-title":"Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis","volume":"35","author":"Huston JM","year":"2007","unstructured":"Huston JM, Gallowitsch-Puerta M, Ochani M,  Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med. 2007;35(12):2762\u20132768."},{"issue":"10","key":"b13","series-title":"Neurogastroenterol Motil","first-page":"e13911","article-title":"A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease","volume":"32","author":"Sinniger V","year":"2020","unstructured":"Sinniger V, Pellissier S, Fauvelle F,  A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease. Neurogastroenterol Motil. 2020;32(10):e13911."},{"issue":"4","key":"b14","series-title":"J Anat","first-page":"588","article-title":"The anatomical basis for transcutaneous auricular vagus nerve stimulation","volume":"236","author":"Butt MF","year":"2020","unstructured":"Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat. 2020;236(4):588\u2013611."},{"key":"b15","series-title":"medRxiv","article-title":"Non-invasive auricular vagus nerve stimulation for subarachnoid hemorrhage (NAVSaH): protocol for a prospective, triple-blinded, randomized controlled trial","author":"Huguenard AL","unstructured":"Huguenard AL, Tan G, Johnson GW,  Non-invasive auricular vagus nerve stimulation for subarachnoid hemorrhage (NAVSaH): protocol for a prospective, triple-blinded, randomized controlled trial. medRxiv. Preprint posted online March 19, 2024. doi:10.1101\/2024.03.18.24304239."},{"key":"b16","series-title":"BMJ","first-page":"c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz KF","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332."},{"key":"b17","series-title":"Front Neurosci","first-page":"284","article-title":"Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice","volume":"14","author":"Yap JYY","year":"2020","unstructured":"Yap JYY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T. Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice. Front Neurosci. 2020;14:284."},{"key":"b18","series-title":"Front Psychol","first-page":"1159","article-title":"Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during sequential action","volume":"9","author":"Jongkees BJ","year":"2018","unstructured":"Jongkees BJ, Immink MA, Finisguerra A, Colzato LS. Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during sequential action. Front Psychol. 2018;9:1159."},{"issue":"1","key":"b19","series-title":"J Neurosurg","first-page":"152","article-title":"Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"133","author":"Athiraman U","year":"2019","unstructured":"Athiraman U, Aum D, Vellimana AK,  Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019;133(1):152\u2013158."},{"issue":"7","key":"b20","series-title":"J Investig Med","first-page":"1054","article-title":"Early elevation of serum tumor necrosis factor-\u03b1 is associated with poor outcome in subarachnoid hemorrhage","volume":"60","author":"Chou SHY","year":"2012","unstructured":"Chou SHY, Feske SK, Atherton J,  Early elevation of serum tumor necrosis factor-\u03b1 is associated with poor outcome in subarachnoid hemorrhage. J Investig Med. 2012;60(7):1054\u20131058."},{"issue":"3","key":"b21","series-title":"Neurocrit Care","first-page":"679","article-title":"TNF-R1 correlates with cerebral perfusion and acute ischemia following subarachnoid hemorrhage","volume":"33","author":"Fragata I","year":"2020","unstructured":"Fragata I, Bustamante A, Penalba A,  TNF-R1 correlates with cerebral perfusion and acute ischemia following subarachnoid hemorrhage. Neurocrit Care. 2020;33(3):679\u2013687."},{"issue":"1","key":"b22","series-title":"Stroke","first-page":"212","article-title":"Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage","volume":"32","author":"Aihara Y","year":"2001","unstructured":"Aihara Y, Kasuya H, Onda H, Hori T, Takeda J. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke. 2001;32(1):212\u2013217."},{"issue":"4","key":"b23","series-title":"J Neurol Neurosurg Psychiatry","first-page":"534","article-title":"Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries","volume":"70","author":"Fassbender K","year":"2001","unstructured":"Fassbender K, Hodapp B, Rossol S,  Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70(4):534\u2013537."},{"issue":"1","key":"b24","series-title":"Sci Rep","first-page":"12","article-title":"Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage","volume":"11","author":"Ridwan S","year":"2021","unstructured":"Ridwan S, Grote A, Simon M. Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage. Sci Rep. 2021;11(1):12."},{"issue":"Pt 1","key":"b25","series-title":"Acta Neurochir Suppl","first-page":"203","article-title":"The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage","volume":"110","author":"Ni W","year":"2011","unstructured":"Ni W, Gu YX, Song DL, Leng B, Li PL, Mao Y. The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;110(Pt 1):203\u2013208."},{"issue":"9","key":"b26","series-title":"Curr Neuropharmacol","first-page":"1385","article-title":"Inflammatory events following subarachnoid hemorrhage (SAH)","volume":"16","author":"Schneider UC","year":"2018","unstructured":"Schneider UC, Xu R, Vajkoczy P. Inflammatory events following subarachnoid hemorrhage (SAH). Curr Neuropharmacol. 2018;16(9):1385\u20131395."},{"issue":"2","key":"b27","series-title":"Neurosurgery","first-page":"289","article-title":"The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study","volume":"40","author":"Manno EM","year":"1997","unstructured":"Manno EM, Gress DR, Ogilvy CS, Stone CM, Zervas NT. The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study. Neurosurgery. 1997;40(2):289\u2013293."},{"issue":"3","key":"b28","series-title":"J Neurosurg","first-page":"681","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage","volume":"112","author":"Gomis P","year":"2010","unstructured":"Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2010;112(3):681\u2013688."},{"key":"b29","series-title":"World Neurosurg","first-page":"e655","article-title":"A propensity score analysis of the impact of dexamethasone use on delayed cerebral ischemia and poor functional outcomes after subarachnoid hemorrhage","volume":"109","author":"Mohney N","year":"2018","unstructured":"Mohney N, Williamson CA, Rothman E,  A propensity score analysis of the impact of dexamethasone use on delayed cerebral ischemia and poor functional outcomes after subarachnoid hemorrhage. World Neurosurg. 2018;109:e655\u2013e661."},{"issue":"1-2","key":"b30","series-title":"Cerebrovasc Dis","first-page":"59","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura M","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis. 2017;44(1-2):59\u201367."},{"issue":"1","key":"b31","series-title":"J Neurosurg","first-page":"121","article-title":"Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial","volume":"118","author":"Senbokuya N","year":"2013","unstructured":"Senbokuya N, Kinouchi H, Kanemaru K,  Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118(1):121\u2013130."},{"issue":"2","key":"b32","series-title":"J Neurosurg","first-page":"515","article-title":"Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study","volume":"128","author":"Galea J","year":"2018","unstructured":"Galea J, Ogungbenro K, Hulme S,  Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg. 2018;128(2):515\u2013523."},{"issue":"12","key":"b33","series-title":"Am J Emerg Med","first-page":"1940","article-title":"Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"35","author":"Liu H","year":"2017","unstructured":"Liu H, Xu X. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Am J Emerg Med. 2017;35(12):1940\u20131945."},{"issue":"4","key":"b34","series-title":"Cochrane Database Syst Rev","first-page":"CD006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Dorhout Mees SM","year":"2007","unstructured":"Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJE. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(4):CD006184."},{"issue":"1","key":"b35","series-title":"J Neurosurg","first-page":"180","article-title":"Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials","volume":"119","author":"Shen J","year":"2013","unstructured":"Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. J Neurosurg. 2013;119(1):180\u2013189."},{"issue":"12","key":"b36","series-title":"J Clin Med","first-page":"4165","article-title":"Anti-inflammatory drug therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective randomized and placebo-controlled trials","volume":"12","author":"Wach J","year":"2023","unstructured":"Wach J, Vychopen M, G\u00fcresir A, G\u00fcresir E. Anti-inflammatory drug therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective randomized and placebo-controlled trials. J Clin Med. 2023;12(12):4165."},{"issue":"2","key":"b37","series-title":"Nat Neurosci","first-page":"156","article-title":"Neural regulation of immunity: molecular mechanisms and clinical translation","volume":"20","author":"Pavlov VA","year":"2017","unstructured":"Pavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci. 2017;20(2):156\u2013166."},{"issue":"2","key":"b38","series-title":"J Mol Neurosci","first-page":"217","article-title":"Non-invasive vagus nerve stimulation protects against cerebral ischemia\/reperfusion injury and promotes microglial M2 polarization via interleukin-17A inhibition","volume":"67","author":"Zhao XP","year":"2019","unstructured":"Zhao XP, Zhao Y, Qin XY, Wan LY, Fan XX. Non-invasive vagus nerve stimulation protects against cerebral ischemia\/reperfusion injury and promotes microglial M2 polarization via interleukin-17A inhibition. J Mol Neurosci. 2019;67(2):217\u2013226."},{"issue":"5","key":"b39","series-title":"Stroke","first-page":"1216","article-title":"Noninvasive vagus nerve stimulation prevents ruptures and improves outcomes in a model of intracranial aneurysm in mice","volume":"50","author":"Suzuki T","year":"2019","unstructured":"Suzuki T, Takizawa T, Kamio Y,  Noninvasive vagus nerve stimulation prevents ruptures and improves outcomes in a model of intracranial aneurysm in mice. Stroke. 2019;50(5):1216\u20131223."},{"key":"b40","series-title":"BioMed Res Int","first-page":"628597","article-title":"To look beyond vasospasm in aneurysmal subarachnoid haemorrhage","volume":"2014","author":"Cossu G","year":"2014","unstructured":"Cossu G, Messerer M, Oddo M, Daniel RT. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage. BioMed Res Int. 2014;2014:628597."},{"issue":"1","key":"b41","series-title":"J Neurochem","first-page":"34","article-title":"Central sympathetic nerve activation in subarachnoid hemorrhage","volume":"160","author":"Hasegawa Y","year":"2022","unstructured":"Hasegawa Y, Uchikawa H, Kajiwara S, Morioka M. Central sympathetic nerve activation in subarachnoid hemorrhage. J Neurochem. 2022;160(1):34\u201350."},{"key":"b42","series-title":"eLife","first-page":"RP100088","article-title":"The effect of transcutaneous auricular vagus nerve stimulation on cardiovascular function in subarachnoid hemorrhage patients: a randomized trial","volume":"13","author":"Tan G","year":"2025","unstructured":"Tan G, Huguenard AL, Donovan KM,  The effect of transcutaneous auricular vagus nerve stimulation on cardiovascular function in subarachnoid hemorrhage patients: a randomized trial. eLife. 2025;13:RP100088."},{"issue":"10","key":"b43","series-title":"Reg Anesth Pain Med","first-page":"513","article-title":"Cervical sympathectomy to treat cerebral vasospasm: a scoping review","volume":"48","author":"Bombardieri AM","year":"2023","unstructured":"Bombardieri AM, Heifets BD, Treggiari M, Albers GW, Steinberg GK, Heit JJ. Cervical sympathectomy to treat cerebral vasospasm: a scoping review. Reg Anesth Pain Med. 2023;48(10):513\u2013519."},{"issue":"2","key":"b44","series-title":"Neurotherapeutics","first-page":"497","article-title":"Spreading depolarizations and subarachnoid hemorrhage","volume":"17","author":"Sugimoto K","year":"2020","unstructured":"Sugimoto K, Chung DY. Spreading depolarizations and subarachnoid hemorrhage. Neurotherapeutics. 2020;17(2):497\u2013510."},{"issue":"4","key":"b45","series-title":"Pain","first-page":"797","article-title":"Vagus nerve stimulation inhibits cortical spreading depression","volume":"157","author":"Chen SP","year":"2016","unstructured":"Chen SP, Ay I, Lopes de Morais A,  Vagus nerve stimulation inhibits cortical spreading depression. Pain. 2016;157(4):797\u2013805."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/142\/6\/article-p1720.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/142\/6\/article-p1720.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/142\/6\/article-p1720.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:15:21Z","timestamp":1781187321000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/142\/6\/article-p1720.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":90,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2024.10.jns241643","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}